Healthcare Industry News:  Brainlab 

Devices Oncology

 News Release - November 13, 2006

More Than 2 Million Cancer Patients Treated with BrainLAB m3(R) Shaped Beam Radiosurgery

250th m3 High-Resolution Multileaf Beam Shaper at UMC Health System

WESTCHESTER, Ill., Nov. 13 (HSMN NewsFeed) -- Brainlab AG, a global leader in software-driven systems for targeted, less-invasive medical treatments, has sold its 250th m3 high-resolution micro multileaf beam shaper at University Medical Center (UMC) Health System, Lubbock, Texas. UMC joins a worldwide group of leading healthcare providers that have conducted more than two million single fraction and fractionated stereotactic radiosurgery treatments since the introduction of the Brainlab beam shaping technology in 1997.

UMC is now able to deliver radiosurgery treatments in one of the most effective ways by tailoring beams of radiation precisely to the shape of a patient's tumor. Unlike conventional radiotherapy systems, using a standard resolution Multileaf Collimator (MLC) with a beam shaping resolution of 5mm or 10mm, the Brainlab high-resolution 3mm micro-multileaf beam shaper allows physicians to refine their existing conventional radiotherapy equipment to administer stereotactic radiosurgery (SRS) treatments that require a high level of accuracy. For SRS treatments, a high dose of radiation is delivered in order to destroy the tumor in a single treatment session.

The high-resolution beam shaping capability of the m3 enables physicians to deliver SRS treatments according to strict radiosurgery dose precision requirements issued by the American Association of Medical Physics (AAPM report #54, SRS). Therefore, it allows for significant reduction of harm to surrounding healthy tissue and minimizes negative side effects. The m3 has also helped reduce treatment length from 30-45 minutes -- typical of basic radiosurgery systems -- to just 20 minutes.

"After comparing a number of different solutions, we selected the Brainlab m3 because its high-resolution beam shaping technology enables us to deliver highly accurate doses that can be tailored to the irregular shape of tumors. As a result, our patients will benefit from shorter treatment times and fewer side effects," said Everado Cobos, MD, medical director of UMC's Southwest Cancer Treatment and Research Center. "Another key consideration was the vast experience of the Brainlab user group in conformal radiosurgery and the ability to tap into this knowledge of m3 and Novalis®."

The Brainlab beam shaping technology has become the standard of care in conformal SRS, whether used to convert conventional linear accelerators to a precise radiosurgery tool, or integrated into the Novalis system -- a turnkey image-guided radiosurgery system that offers the highest level of accuracy and efficiency.

"UMC is joining a worldwide network of 250 healthcare centers that use the m3 high-resolution micro-multileaf beam shaping technology to refine their existing conventional radiotherapy equipment. UMC's acquisition is a testimony to the power of our technology to administer a safe and highly effective level of patient care," said Ralf Schira, Marketing Manager Oncology Solutions, Brainlab. "The number of sites using this technology around the world has risen by nearly 20 percent in the last year and users delivered more than 400,000 single fraction and fractionated stereotactic treatments in the last 12 months -- the m3 is one of the most clinically-proven technologies of its kind."

About UMC Health System

UMC Health System is the leader in comprehensive healthcare delivery in West Texas and Eastern New Mexico. Founded in 1978, it is home to the region's only level I trauma center, the Timothy J. Harnar Burn Center, the UMC Heart Center, the UMC Southwest Cancer Treatment and Research Center, and the UMC Children's Hospital.

About Brainlab

Brainlab develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and therefore less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. This utility has been further expanded to serve as a computer terminal for physicians to more effectively access and interpret diagnostic scans and other digital medical information for better informed decisions. Brainlab solutions allow expansion from a single system to operating suites to digitally integrated hospitals covering all subspecialties from neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology. With more than 2,500 systems installed in over 65 countries, Brainlab is a market leader in image-guided technology. The privately held Brainlab group, founded in 1989, is headquartered in Munich, Germany and today employs around 900 people in 15 offices across Europe, Asia, Australia, North and South America.

For more information, visit Brainlab at http://www.Brainlab.com .

® registered trademark of Brainlab in Germany and/or the US


Source: BrainLAB

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.